Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L Dignan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Oncologist|October 21, 2000
Burnout: caring for the caregiversR T Penson, F L Dignan, G P Canellos, et al.
The Journal of Hospital Infection|January 13, 2017
Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipientsC M Gorcea, E Tholouli, A Turner, et al.
Bone Marrow Transplantation|February 11, 2014
Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AMLC Anthias, F L Dignan, R Morilla, et al.
Clinical Transplantation|December 11, 2012
A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivorsF L Dignan, R Manwani, M N Potter, et al.
Bone Marrow Transplantation|October 14, 2014
A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequentJ J Scarisbrick, F L Dignan, S Tulpule, et al.
Bone Marrow Transplantation|January 14, 2009
An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortalityF L Dignan, S O Evans, M E Ethell, et al.
Bone Marrow Transplantation|February 26, 2014
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHDF L Dignan, S Aguilar, J J Scarisbrick, et al.
Bone Marrow Transplantation|September 20, 2011
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHDF L Dignan, D Greenblatt, M Cox, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Oncologist|October 21, 2000
Burnout: caring for the caregiversR T Penson, F L Dignan, G P Canellos, et al.
The Journal of Hospital Infection|January 13, 2017
Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipientsC M Gorcea, E Tholouli, A Turner, et al.
Bone Marrow Transplantation|February 11, 2014
Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AMLC Anthias, F L Dignan, R Morilla, et al.
Clinical Transplantation|December 11, 2012
A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivorsF L Dignan, R Manwani, M N Potter, et al.
Bone Marrow Transplantation|October 14, 2014
A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequentJ J Scarisbrick, F L Dignan, S Tulpule, et al.
Bone Marrow Transplantation|January 14, 2009
An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortalityF L Dignan, S O Evans, M E Ethell, et al.
Bone Marrow Transplantation|February 26, 2014
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHDF L Dignan, S Aguilar, J J Scarisbrick, et al.
Bone Marrow Transplantation|September 20, 2011
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHDF L Dignan, D Greenblatt, M Cox, et al.
Pageof 1